Origin of DSS: to present the plan

The field of neurological assessment has evolved significantly, particularly in the context of chronic diseases like multiple sclerosis. Prior to the development of standardized scales, neurological evaluations relied heavily on subjective observations and fragmented documentation. The need for a systematic way to track disease progression became evident as patient records grew in complexity. Academic medicine played a key role in advancing clinical evaluation methods, especially through post-war institutional reforms. The Veterans Administration (VA) system contributed to this shift by integrating research and patient care. Medical training programs, such as those under the GI Bill, emphasized detailed neurological documentation. These programs laid the groundwork for more structured diagnostic approaches. However, a unified system for measuring neurological deficits remained absent. This gap motivated the development of a comprehensive scale that could track changes over time.

This paper outlines the historical development of the Disability Status Scale (DSS) for multiple sclerosis. The primary aim is to document how the scale emerged from clinical and academic practices in the post-World War II era. The authors seek to explain the rationale behind creating a standardized system for measuring neurological deficits. They also aim to clarify how this system was adapted and expanded into the Expanded Disability Status Scale (EDSS). The study highlights the importance of detailed neurological documentation in training and research. It emphasizes the role of VA hospitals in refining clinical evaluation methods. The purpose includes showing how the DSS provided a framework for tracking disease progression. The paper also aims to explain the limitations of rank-order scales and how they were addressed in the DSS design.

The development of the DSS was rooted in clinical training and patient record analysis. The authors relied on extensive neurological documentation from VA hospitals. They categorized neurological deficits into distinct Functional Systems. Each system was assigned severity grades to reflect the extent of impairment. These grades were based on rank-order scales, which could not be summed directly. The authors used patient records from over 300 MS cases to establish baseline data. They compared these records to assess changes in neurological status over time. The DSS was structured to range from 0 to 10, with each step representing increasing disability.

The DSS was created as a tool to measure disability in MS patients systematically. It was derived from Functional Systems with severity grades for each. The scale ranged from 0 to 10, with 0 indicating normal status and 10 representing death due to MS. The authors later expanded the DSS into the EDSS by halving each step from 1 to 9. This bifid system allowed for more granular assessments of disability. The EDSS became widely applicable to all MS patients regardless of disease type or severity. The DSS and EDSS provided a consistent framework for tracking neurological changes. These scales became foundational in MS clinical evaluations and research.

The authors conclude that the DSS emerged from the need for a structured system to measure neurological deficits in MS. They emphasize that the DSS was based on detailed clinical documentation from VA hospitals. The scale was designed to capture disability progression in a standardized way. The expansion into the EDSS improved the scale's precision and applicability. The DSS and EDSS remain relevant for assessing MS severity and tracking changes. The authors suggest that these scales were essential for advancing MS research and clinical care. They note that the VA system played a central role in refining these tools. The study highlights the importance of historical context in shaping modern neurological evaluation methods.